IBRX - ImmunityBio, Inc.
IEX Last Trade
2.48
-0.015 -0.605%
Share volume: 5,561,406
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$2.50
0.06
0.02%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-11 | 2023-08-08 | 2023-11-09 | 2024-03-19 | 2024-05-09 | 2024-08-12 | 2024-11-12 | |
| Cash flow financing | 76.888 M | 43.412 M | 237.502 M | 200.539 M | 10.225 M | 148.894 M | 15.582 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 48.313 M | 15.582 M | |
| Cash flow | -84.310 M | -79.773 M | -87.403 M | -115.271 M | -106.982 M | -2.943 M | -18.149 M | |
| Net income | -116.343 M | -137.879 M | -95.582 M | -233.392 M | -134.109 M | -134.584 M | -85.752 M | |
| Depreciation | 4.681 M | 4.682 M | 4.585 M | 4.564 M | 4.555 M | 4.406 M | 4.455 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 1.464 M | 2.025 M | 2.325 M | 2.019 M | 2.137 M | 0.000 | 0.000 | |
| Investing Cashflow | -8.484 M | -8.604 M | -15.631 M | 2.249 M | -35.622 M | -51.490 M | 65.032 M | |
| Net Borrowings | 654.229 M | 754.356 M | 504.509 M | 330.072 M | 537.782 M | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -8.428 M | -8.526 M | -5.675 M | -7.955 M | -1.261 M | 724.000 K | 2.792 M | |
| Cash Change | 91.268 M | 45.954 M | 189.796 M | 266.462 M | 170.495 M | -2.970 M | -18.122 M |